Samsung Organoids

With advanced expertise and technology, Samsung Biologics accelerates the early discovery and evaluation of new drug candidates with Samsung Organoids.

Samsung Organoids pave the way for quality-first, end-to-end support for your drug development journey with patient-derived organoids (PDOs). As a trusted CDMO partner, we expedite your drug development process and ensure the timely delivery of life-saving therapies.

Innovating Drug Development with Avatar-based Predictive Models mobile image
Innovating Drug Development with Avatar-based Predictive Models mobile image

Patient-Derived Tumor Organoids for Precision Screening

Patient-derived organoids are 3D tumor models that mirror individual cancers. We offer precision drug screening to help you identify effective compounds with higher clinical relevance, covering colorectal, lung, liver, gastric, and breast cancers.

Service Offerings

We continuously commit to serving your evolving needs from an early stage. With extensive data and detailed analysis from early discovery to clinical trials, we effectively address key challenges in drug discovery to advance your journey toward clinical success.

Streamlined CDMO Journey with Research Services
  • Target Discovery

    • Therapeutic target validation
    • Disease-relevant organoids
      model development
  • Lead Selection

    • Lead identification
    • Efficacy examination
  • Preclinical
    Development

    • Biomarker identification
    • Drug selection support based
      on multi-modal data
  • Clinical Trial

    • Indication expansion
    • Patient stratification for clinical trial

Features

Samsung Organoids accelerate your drug development journey with precise predictive models and reliable data.

  • Rapid, Bespoke
    Organoid Support
    Accelerated market entry with organoids tailored to your therapeutic target and development stage
  • Comprehensive Analysis
    and Screening
    Deep biological insights with multi-modal tumor data, including WES, RNA-seq, and matched patient profiles
  • Reproducible,
    High-Quality Data
    Quality-assured organoids backed by robust, validated datasets to support confident decision-making in drug screening

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION